Lijie J. Han
Zhengzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 45 publications
Reply to 'Immortal time bias limits the conclusion that post-transplant hypomethylating agent maintenance improves outcomes in myelodysplastic syndromes'.
Journal: British journal of haematology
Published: June 18, 2026
Risk factor analysis and prediction model construction for delayed erythroid hematopoietic reconstitution after allogeneic hematopoietic stem cell transplantation: a single-center retrospective study.
Journal: Frontiers in oncology
Published: April 22, 2026
Contrasting impacts of pretransplant cytoreduction and post-transplant maintenance on outcomes of allogeneic haematopoietic stem cell transplantation in myelodysplastic syndromes: Real-world multicentre evidence.
Journal: British journal of haematology
Published: January 26, 2026
Recent development in bispecific antibody immunotherapy for hematological malignancies.
Journal: Critical reviews in oncology/hematology
Published: March 27, 2025
Bispecific antibodies in immunotherapy for acute leukemia: latest updates from the 66th annual meeting of the American society of hematology, 2024.
Journal: Frontiers in oncology
Published: January 24, 2025
Bispecific antibodies targeting CD20xCD3 in immunotherapy for adult B-cell lymphoma: insights from the 65th American Society of Hematology 2023 annual meeting.
Journal: Expert opinion on biological therapy
Published: May 08, 2024
Multi-omics analysis reveals a feedback loop amplifying immune responses in acute graft-versus-host disease due to imbalanced gut microbiota and bile acid metabolism.
Journal: Journal of translational medicine
Published: April 30, 2024
Bispecific antibodies in immunotherapy for adult acute leukemia: latest updates from the 65th American Society of Hematology 2023 Annual Meeting.
Journal: Expert opinion on biological therapy
Published: March 20, 2024
A novel sub-regional radiomics model to predict immunotherapy response in non-small cell lung carcinoma.
Journal: Journal of translational medicine
Published: November 01, 2023
Bispecific antibodies as monotherapy or in combinations for hematological malignancies: latest updates from the EHA 2023 annual meeting.
Journal: Expert opinion on biological therapy
Published: October 18, 2023
Determining the prognosis of Lung cancer from mutated genes using a deep learning survival model: a large multi-center study.
Journal: Cancer cell international
Published: June 12, 2023
Genetic mutation signature for relapse prediction in normal karyotype acute myeloid leukemia.
Journal: Experimental hematology
Published: June 06, 2023
Last Updated: 09/26/2026